XML 33 R22.htm IDEA: XBRL DOCUMENT
v3.25.1

Stock Option Plan and Stock Based Compensation | 12 Months Ended
--- | ---
Feb. 28, 2025
Share-Based Payment Arrangement [Abstract] |
Stock Option Plan and Stock Based Compensation | (11) Stock Option Plan and Stock Based Compensation The Company grants stock options, restricted stock and restricted stock units (“RSUs”) to key executives and managerial employees and non-employee directors. Prior to June 30, 2021, the Company had one stock incentive plan, the 2004 Long-Term Incentive Plan of Ennis, Inc., as amended and restated as of May 18, 2008 and was further amended on June 30, 2011 (the "Old Plan"). The Old Plan expired June 30, 2021 and all remaining unused shares expired. Subject to the affirmative vote of the shareholders, the Board adopted the 2021 Long-Term Incentive Plan of Ennis, Inc. (the "New Plan") on April 16, 2021 authorizing 1,033,648 shares of common stock for awards. The New Plan was approved by the shareholders at the Annual Meeting on July 15, 2021 by a majority vote. The New Plan expires June 30, 2031 and all unissued stock will expire on that date. At fiscal year ended February 28, 2025, the Company has 280,445 shares of unissued common stock reserved under the New Plan for issuance and uses treasury stock to satisfy option exercises and restricted stock awards. The Company recognizes compensation expense for stock options and restricted stock grants on a straight-line basis over the requisite service period. For the fiscal years ended 2025, 2024 and 2023, the Company included in selling, general and administrative expenses, compensation expense related to share based compensation of $2.9 million, $2.5 million and $2.8 million, respectively. Stock Options No stock options were granted during fiscal year 2025 and 2023. The following is a summary of the assumptions used and the weighted average grant-date fair value of the stock options granted during the fiscal year ended February 29, 2024.
|  | February 29, |
|  | 2024 |
Expected volatility |  |  | 19.55 | %
Expected term (years) |  |  | 3 |
Risk free interest rate |  |  | 3.87 | %
Dividend Yield |  |  | 4.94 | %
Weighted average grant-date fair value |  | $ | 2.47 |
A summary of the status of the Company’s unvested stock options at February 28, 2025 are presented below:
|  |  |  |  | Weighted |
|  |  |  |  | Average |
|  | Number |  |  | Grant Date |
|  | of Options |  |  | Fair Value |
Unvested at March 1, 2024 |  |  | 52,500 |  |  | $ | 2.47 |
New grants |  |  | — |  |  |  | — |
Vested |  |  | (17,497 | ) |  |  | 2.47 |
Forfeited |  |  | (8,334 | ) |  |  | 2.47 |
Unvested at February 28, 2025 |  |  | 26,669 |  |  | $ | 2.47 |
As of February 28, 2025, there was less than $0.1 million of unrecognized compensation cost related to unvested stock options granted under the Plan. The weighted average remaining requisite service period of the unvested stock options was 1.1 years. All outstanding options had an exercise price of $19.88. Restricted Stock The following occurred with respect to the Company’s restricted stock awards for each of the three fiscal years ended February 28, 2025:
|  |  |  | Weighted |
|  |  |  | Average |
| Number of |  |  | Grant Date |
| Shares |  |  | Fair Value |
Outstanding at March 1, 2022 |  | 67,164 |  |  | $ | 18.73 |
Granted |  | 22,000 |  |  |  | 19.78 |
Terminated |  | — |  |  |  | — |
Vested |  | (39,381 | ) |  |  | 19.00 |
Outstanding at February 28, 2023 |  | 49,783 |  |  | $ | 18.99 |
Granted |  | 21,672 |  |  |  | 20.31 |
Terminated |  | — |  |  |  | — |
Vested |  | (29,324 | ) |  |  | 18.36 |
Outstanding at February 29, 2024 |  | 42,131 |  |  | $ | 20.11 |
Granted |  | 19,880 |  |  |  | 23.24 |
Terminated |  | — |  |  |  | — |
Vested |  | (20,344 | ) |  |  | 20.08 |
Outstanding at February 28, 2025 |  | 41,667 |  |  | $ | 21.61 |
The total fair value of restricted stock awards vested during fiscal 2025, 2024 and 2023 were $0.5 million, $0.6 million, and $0.8 million, respectively. As of February 28, 2025, the total remaining unrecognized compensation cost related to unvested restricted stock was approximately $0.6 million. The weighted average remaining requisite service period of the unvested restricted stock awards was 1.7 years. As of February 28, 2025, the Company’s outstanding restricted stock had an underlying fair value of $0.9 million at date of grant. Restricted Stock Units During fiscal year 2025, 183,457 performance-based RSUs and 122,303 time-based RSUs were granted under the New Plan. The fair value of the time-based RSUs was estimated based on the fair market value of the Company’s stock on the date of grant of $19.43 per unit. The fair value of the performance-based RSUs, using a Monte Carlo valuation model, was $19.97 per unit. The performance measures include a threshold, target and maximum performance level providing the grantees an opportunity to receive more or less shares than targeted depending on actual financial performance. The award will be based on the Company’s return on equity, EBITDA and adjusted for the Company’s Relative Shareholder Return as measured against a defined peer group. Holders of RSUs receive cash dividends equal to the dividends we declare and pay on our common stock, which are included in dividends paid in the Condensed Consolidated Financial Statements. The performance-based RSUs will vest no later than March 15, 2027, which is the deadline for the Compensation Committee to determine the extent of the Company’s attainment of the Performance Goals during the Performance Period that ends on February 28, 2027. The time-based RSUs vest ratably over three years from the date of grant. The following occurred with respect to the Company’s restricted stock units ("RSUs") for fiscal years 2023, 2024 and 2025:
| Time-based |  |  | Performance-based |
|  |  |  | Weighted |  |  |  |  |  | Weighted |
|  |  |  | Average |  |  |  |  |  | Average |
| Number of |  |  | Grant Date |  |  | Number of |  |  | Grant Date |
| Shares |  |  | Fair Value |  |  | Shares |  |  | Fair Value |
Outstanding at March 1, 2022 |  | 35,071 |  |  | $ | 20.38 |  |  |  | 140,287 |  |  | $ | 23.17 |
Granted |  | 9,893 |  |  |  | 19.47 |  |  |  | 93,532 |  |  |  | 23.17 |
Terminated |  | — |  |  |  | — |  |  |  | — |  |  |  | — |
Vested |  | (11,690 | ) |  |  | 20.38 |  |  |  | — |  |  |  | — |
Outstanding at February 28, 2023 |  | 33,274 |  |  | $ | 20.11 |  |  |  | 233,819 |  |  | $ | 23.17 |
Granted |  | — |  |  |  | — |  |  |  | — |  |  |  | — |
Terminated |  | — |  |  |  | — |  |  |  | (81,247 | ) |  |  | 20.32 |
Vested |  | (16,635 | ) |  |  | 20.11 |  |  |  | — |  |  |  | — |
Outstanding at February 29, 2024 |  | 16,639 |  |  | $ | 20.11 |  |  |  | 152,572 |  |  | $ | 23.17 |
Granted (1) |  | 122,303 |  |  |  | 19.43 |  |  |  | 238,494 |  |  |  | 19.97 |
Change due to performance achievement |  | — |  |  |  | — |  |  |  | 61,337 |  |  |  | — |
Terminated |  | (8,695 | ) |  |  | 19.43 |  |  |  | (29,462 | ) |  |  | 19.97 |
Vested |  | (28,286 | ) |  |  | 19.83 |  |  |  | (224,114 | ) |  |  | 22.59 |
Outstanding at February 28, 2025 |  | 101,961 |  |  | $ | 19.43 |  |  |  | 198,827 |  |  | $ | 19.97 |
(1) The number of shares of time-based grants may, upon vesting, convert 50% into common stock and the remaining 50% into two incentive stock options for each RSU with an exercise price equal to the closing price of the Company's stock on that date for employees who have not met their stock ownership requirements. The number of shares of performance-based grants includes an estimate 55,037 of additional RSUs at the maximum achievement level of 130% of target payout. Actual shares that may be issued can range from 0% to 130% of target. The total fair value of restricted stock unit awards vested during fiscal 2025, 2024 and 2023 were $4.9 million, $0.3 million and $0.2 million, respectively. Performance based RSUs vesting during fiscal year 2024 include triennial performance-based RSUs intended to compensate executive officers over its three year measurement period of fiscal year 2022 through fiscal year 2024. The compensation expense related to the vesting was recognized over the applicable vesting period of the award. In addition, there was an accelerated vesting of 29,118 shares upon the retirement of an executive officer. As of February 28, 2025, the total remaining unrecognized compensation cost of time-based RSUs was approximately $1.4 million over a weighted average remaining requisite service period of 2.1 years. The total remaining unrecognized compensation of performance-based RSUs was approximately $2.8 million over a weighted average remaining requisite service period of 2.1 years. As of February 28, 2025, the Company’s outstanding RSUs had an underlying fair value of $6.4 million at date of grant.

X
- Definition The entire disclosure for share-based payment arrangement. + References Reference 1: http://www.xbrl.org/2003/role/exampleRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/718/tableOfContent Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (h)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (h)(2)(i) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (l) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration